Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
GABA(A) (gamma-aminobutyric acid(A)) receptors are molecular substrates for the regulation of vigilance, anxiety, muscle tension, epileptogenic activity and memory functions, which is evident from the spectrum of actions elicited by clinically effective drugs acting at their modulatory benzodiazepine-binding site. Here we show, by introducing a histidine-to-arginine point mutation at position 101 of the murine alpha1-subunit gene, that alpha1-type GABA(A) receptors, which are mainly expressed in cortical areas and thalamus, are rendered insensitive to allosteric modulation by benzodiazepine-site ligands, whilst regulation by the physiological neurotransmitter gamma-aminobutyric acid is preserved. alpha1(H101R) mice failed to show the sedative, amnesic and partly the anticonvulsant action of diazepam. In contrast, the anxiolytic-like, myorelaxant, motor-impairing and ethanol-potentiating effects were fully retained, and are attributed to the nonmutated GABA(A) receptors found in the limbic system (alpha2, alpha5), in monoaminergic neurons (alpha3) and in motoneurons (alpha2, alpha5). Thus, benzodiazepine-induced behavioural responses are mediated by specific GABA(A) receptor subtypes in distinct neuronal circuits, which is of interest for drug design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on in vivo point mutations, a-1-GABA A receptors have been found to mediate sedation and anterograde amnesia and to partially mediate anticonvulsant activity, whereas a-2-GABA A receptors mediate anxiolysis (14,15).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [15]
In the citing paper
“There is also evidence suggesting the involvement of α1GABAARs [62, 63], α2GABAARs [50], and α4/δGABAARs in learning and memory [64-68].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
Citations
Cites
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
Benzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700
Self-citationFritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Self-citationSelective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
Self-citationBarnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Self-citationEfficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
A simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
High densities of benzodiazepine receptors in human cortical areas
BRAESTRUP, C., ALBRECHTSEN, R., & SQUIRES, R. F. (1977) · Nature · doi:10.1038/269702a0 · Cited by 414
Fritschy, J. M., Benke, D., Mertens, S., Oertel, W. H., Bachi, T., & Möhler, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6726 · Cited by 344
Self-citation
Research works printed but not linked: 2
- Knoflach,F. et al. Pharmacological modulation of the diazepam-insensitive recombinant γ-aminobutyric acidA receptors α4β2γ2 and α6β2γ2. Mol. Pharmacol. 50, 1253–1261 (1996).
- Bernard,F. et al. in Zolpidem: an Update of its Pharmacological Properties and the Therapeutic Place in the Management of Insomnia (eds Freeman, H., Puech, A. J. & Roth, T.) 21–31 (Elsevier, Paris, 1996).
Cited by
Items 201–300 of 1,001
GABAAReceptor α5 Subunits Contribute to GABAA,slowSynaptic Inhibition in Mouse Hippocampus
Zarnowska, E. D., Keist, R., Rudolph, U., & Pearce, R. A. (2009) · Journal of Neurophysiology · doi:10.1152/jn.91203.2008 · Cited by 104
Self-citationFunctional mapping of GABAA receptor subtypes in the amygdala
Marowsky, A., Fritschy, J., & Vogt, K. E. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03574.x · Cited by 118
Self-citationCardin, J. A., & Schmidt, M. F. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00391.2003 · Cited by 118
Ralvenius, W. T., Benke, D., Acuña, M. A., Rudolph, U., & Zeilhofer, H. U. (2015) · Nature Communications · doi:10.1038/ncomms7803 · Cited by 117
Self-citationMorris, H. V., Dawson, G. R., Reynolds, D. S., Atack, J. R., & Stephens, D. N. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04775.x · Cited by 117
Ohl, F., Sillaber, I., Binder, E., Keck, M. E., & Holsboer, F. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00017-6 · Cited by 117
Endogenous Positive Allosteric Modulation of GABAA Receptors by Diazepam binding inhibitor
Christian, C. A., Herbert, A. G., Holt, R. L., Peng, K. K., Sherwood, K. D., Pangratz-Fuehrer, S., Rudolph, U., & Huguenard, J. R. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.026 · Cited by 116
Self-citationHippocampal α5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition
Hauser, J., Rudolph, U., Keist, R., Möhler, H., Feldon, J., & Yee, B. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001554 · Cited by 116
Self-citationPrinciples of Antiepileptic Drug Action
Rogawski, M. A. (2002) · Cited by 115
A novel GABAAreceptor pharmacology: drugs interacting with the α+β‐interface
Sieghart, W., Ramerstorfer, J., Sarto‐Jackson, I., Varagić, Z., & Ernst, M. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01779.x · Cited by 111
Anxioselective anxiolytics: on a quest for the Holy Grail
Skolnick, P. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.08.003 · Cited by 111
Benzodiazepines and risk of all cause mortality in adults: cohort study
Patorno, E., Glynn, R. J., Levin, R., Lee, M. P., & Huybrechts, K. F. (2017) · BMJ · doi:10.1136/bmj.j2941 · Cited by 98
CAPON-nNOS coupling can serve as a target for developing new anxiolytics
Zhu, L., Li, T., Luo, C., Jiang, N., Chang, L., Lin, Y., Zhou, H.-H., Chen, C., Zhang, Y., Lü, W., et al. (2014) · Nature Medicine · doi:10.1038/nm.3644 · Cited by 109
Kittler, J. T., McAinsh, K., & Moss, S. J. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:251 · Cited by 108
Evans, A. K., & Lowry, C. A. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00025.x · Cited by 107
Collinson, N., Atack, J. R., Laughton, P., Dawson, G. R., & Stephens, D. N. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0361-z · Cited by 106
GABA Receptors and the Pharmacology of Sleep
Wisden, W., Yu, X., & Franks, N. P. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_56 · Cited by 105
The fallacy of behavioral phenotyping without standardisation
Van Der Staay, F. J., & Steckler, T. (2002) · Genes, Brain and Behavior · doi:10.1046/j.1601-1848.2001.00007.x · Cited by 100
Gafford, G. M., Guo, J.-D., Flandreau, E. I., Hazra, R., Rainnie, D. G., & Ressler, K. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119261109 · Cited by 96
de Haas, S. L., de Visser, S. J., Post, J. P. V. D., Schoemaker, R. C., Dyck, K. V., Murphy, M. G., Smet, M. D., Vessey, L. K., Ramakrishnan, R., Xue, L., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107082108 · Cited by 105
Shisa7 is a GABA A receptor auxiliary subunit controlling benzodiazepine actions
Han, W., Li, J., Pelkey, K. A., Pandey, S., Chen, X., Wang, Y.-X., Wu, K., Ge, L., Li, T., Castellano, D., et al. (2019) · Science · doi:10.1126/science.aax5719 · Cited by 95
Thompson, S. M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01728-8 · Cited by 103
The 5-HT 1A receptor knockout mouse and anxiety
Olivier, B., Pattij, T., Wood, S. J., Oosting, R., Sarnyai, Z., & Toth, M. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00004 · Cited by 89
Contribution of sedative-hypnotic agents to delirium via modulation of the sleep pathway
Sanders, R., & Maze, M. (2010) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-010-9421-2 · Cited by 101
Sohal, V. S., Keist, R., Rudolph, U., & Huguenard, J. R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03649.2003 · Cited by 101
Self-citationGABAA receptor subtype involvement in addictive behaviour
Stephens, D. N., King, S. L., Lambert, J. J., Belelli, D., & Duka, T. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12321 · Cited by 101
The benzodiazepine site of the GABA receptor: an old target with new potential?
Bateson, A. N. (2004) · Sleep Medicine · doi:10.1016/s1389-9457(04)90002-0 · Cited by 100
Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles
Prevot, T. D., Li, G., Vidojevic, A., Misquitta, K. A., Fee, C., Santrac, A., Knutson, D. E., Stephen, M. R., Kodali, R., Zahn, N. M., et al. (2019) · Complex Psychiatry · doi:10.1159/000496086 · Cited by 86
Drug Burden Index, Physical Function, and Adverse Outcomes in Older Hospitalized Patients
Lowry, E., Woodman, R. J., Soiza, R. L., Hilmer, S. N., & Mangoni, A. A. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011421489 · Cited by 99
The Role of Benzodiazepines in the Treatment of Epilepsy
Ochoa, J. G., & Kilgo, W. A. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0401-x · Cited by 99
Lio, A. D., Benke, D., Besson, M. J., Desmeules, J. A., Daali, Y., Wang, Z., Edwankar, R. V., Cook, J. M., & Zeilhofer, H. U. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.026 · Cited by 98
Self-citationBrown, M. W., Barker, G. R. I., Aggleton, J. P., & Warburton, E. C. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.07.034 · Cited by 98
Uslaner, J. M., Tye, S. J., Eddins, D. M., Wang, X., Fox, S. V., Savitz, A. T., Binns, J., Cannon, C. E., Garson, S. L., Yao, L., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005213 · Cited by 91
The Reinforcing Properties of Alcohol are Mediated by GABAA1 Receptors in the Ventral Pallidum
June, H. L., Foster, K. L., McKay, P. F., Seyoum, R., Woods, J. E., Harvey, S. C., Eiler, W. J. A., Grey, C., Carroll, M. R., McCane, S., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300239 · Cited by 97
Unraveling the function of GABAA receptor subtypes
Sieghart, W. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01564-9 · Cited by 95
Smith, K. S., Engin, E., Meloni, E. G., & Rudolph, U. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.001 · Cited by 94
Self-citationNanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study
Eleraky, N. E., Omar, M. M., Mahmoud, H. A., & Abou‐Taleb, H. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050451 · Cited by 94
Cerne, R., LIPPA, A. S., Poe, M. M., Smith, J. L., Jin, X., Ping, X., Golani, L. K., Cook, J. M., & Witkin, J. M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108035 · Cited by 94
Shi, Y., Cui, M., Ochs, K., Brendel, M., Strübing, F., Briel, N., Eckenweber, F., Zou, C., Banati, R. B., Liu, G. J., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01013-9 · Cited by 94
Self-citationGABAA receptor subtypes and benzodiazepine use, misuse, and abuse
Engin, E. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1060949 · Cited by 94
Benke, D., Fakitsas, P., Roggenmoser, C., Michel, C., Rudolph, U., & Mohler, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407154200 · Cited by 80
Self-citationGABAergic systems in the vestibular nucleus and their contribution to vestibular compensation
Gliddon, C. M., DARLINGTON, C., & Smith, P. R. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.11.001 · Cited by 94
Gonçalves, J. F., Nicoloso, F. T., da Costa, P., Farias, J. G., Carvalho, F. B., da Rosa, M. M., Gutierres, J. M., Abdalla, F. H., Pereira, J. S. F., Dias, G. R. M., et al. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.07.016 · Cited by 93
Olsen, R. W. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2014.11.005 · Cited by 93
A precritical period for plasticity in visual cortex
Feller, M. B., & Scanziani, M. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.01.012 · Cited by 92
Allen, K. L., Waldvogel, H. J., Glass, M., & Faull, R. L. M. (2009) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2009.02.001 · Cited by 92
Goldstein, P. A., Elsen, F. P., Ying, S., Ferguson, C., Homanics, G. E., & Harrison, N. L. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00885.2001 · Cited by 92
Biflavones from Rhus species with affinity for the GABAA/benzodiazepine receptor
Svenningsen, A. B., Madsen, K. D., Liljefors, T., Stafford, G. I., van Staden, J., & Jäger, A. K. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.08.012 · Cited by 91
The reappraisal of benzodiazepines in the treatment of anxiety and related disorders
Starcevic, V. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.963057 · Cited by 90
Izzo, E., Auta, J., Impagnatiello, F., Pesold, C., Guidotti, A., & Costa, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051628698 · Cited by 90
The Role of GABA Receptors in Anesthesia and Sedation: An Updated Review
Philip, A. B., Brohan, J., & Goudra, B. (2024) · CNS Drugs · doi:10.1007/s40263-024-01128-6 · Cited by 91
Privileged Diazepine Compounds and Their Emergence as Bromodomain Inhibitors
Smith, S. G., Sánchez, R., & Zhou, M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.03.004 · Cited by 90
Robin, C., & Trieger, N. (2002) · PubMed · Cited by 89
Benzodiazepine Augmented γ-Amino-Butyric Acid Signaling Increases Mortality From Pneumonia in Mice*
Sanders, R. D., Godlee, A., Fujimori, T., Goulding, J., Xin, G., Salek-Ardakani, S., Snelgrove, R. J., Ma, D., Maze, M., & Hussell, T. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827c0c8d · Cited by 81
Benzodiazepine impairment of perirhinal cortical plasticity and recognition memory
Wan, H., Warburton, E. C., Zhu, X. O., Koder, T., Park, Y., Aggleton, J. P., Cho, K., Bashir, Z. I., & Brown, M. W. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03688.x · Cited by 89
Mirza, N. R., Larsen, J. S., Mathiasen, C., Jacobsen, T. A., Munro, G., Erichsen, H. K., Nielsen, A. N., Troelsen, K. B., NIELSEN, E. O., & Ahring, P. K. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138859 · Cited by 89
Marder, M., Estiu, G. L., Bruno‐Blanch, L. E., Viola, H., Wasowski, C., Medina, J. H., & Paladini, A. C. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00250-9 · Cited by 89
Follesa, P., Concas, A., Porcu, P., Sanna, E., Serra, M., Mostallino, M. C., Purdy, R. H., & Biggio, G. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00125-4 · Cited by 88
Abuse, Dependence, and Epileptic Seizures after Zolpidem Withdrawal[colon] Review and Case Report
Aragona, M. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200009000-00008 · Cited by 88
Maramai, S., Benchekroun, M., Ward, S. E., & Atack, J. R. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01312 · Cited by 87
Nishikawa, K., Jenkins, A., Paraskevakis, I., & Harrison, N. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00189-7 · Cited by 87
Wu, L., Ko, S. W., Toyoda, H., Zhao, M., Xu, H., Vadakkan, K. I., Ren, M., Knifed, E., Shum, F. W. F., Quan, J., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000167 · Cited by 87
Mizokami, A., Kanematsu, T., Ishibashi, H., Yamaguchi, T., Tanida, I., Takenaka, K., Nakayama, K. I., Fukami, K., Takenawa, T., Kominami, E., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3155-06.2007 · Cited by 87
GABAA Receptor α2/α3 Subtype-Selective Modulators as Potential Nonsedating Anxiolytics
Atack, J. R. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_30 · Cited by 86
GABAA receptor subtypes underlying general anesthesia
Bonin, R. P., & Orser, B. A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.12.011 · Cited by 85
Griebel, G., Perrault, G., Simiand, J., Cohen, C., Granger, P., Depoortere, H., Françon, D., Avenet, P., Schoemaker, H., Evanno, Y., et al. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00241.x · Cited by 85
Endozepines and their receptors: Structure, functions and pathophysiological significance
Tonon, M.-C., Vaudry, H., Chuquet, J., Guillebaud, F., Fan, J., Masmoudi-Kouki, O., Vaudry, D., Lanfray, D., Morin, F., Prevot, V., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.008 · Cited by 71
de Haas, S. L., de Visser, S. J., van der Post, J. P., de Smet, M., Schoemaker, R. C., Rijnbeek, B., Cohen, A. F., Vega, J. M., Agrawal, N. G. B., Goel, T. V., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106072343 · Cited by 84
“The 1 subtype appears to be involved in the sedative effects (Rudolph et al., 1999; McKernan et al., 2000; Rudolph et al., 2001; Griebel et al., 2001; Tobler et al., 2001).”
BackgroundMunro, G., Ahring, P. K., & Mirza, N. R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.004 · Cited by 84
Cooper, S. J. (2005) · Appetite · doi:10.1016/j.appet.2005.01.003 · Cited by 84
Hendershott, T. R., Cronin, M. E., Langella, S., McGuinness, P. S., & Basu, A. C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.004 · Cited by 83
Research in anxiety disorders: From the bench to the bedside
Garner, M. J., Möhler, H., Stein, D. J., Mueggler, T., & Baldwin, D. S. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.011 · Cited by 83
Self-citationHuen, M. S. Y., Leung, J. W. C., Ng, W., Lui, W., Chan, M. N. S., Wong, J. T.-F., & Xue, H. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00233-8 · Cited by 83
GABA Pharmacology: The Search for Analgesics
McCarson, K. E., & Enna, S. J. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1254-x · Cited by 82
Cremer, C. M., Palomero‐Gallagher, N., Bidmon, H. J., Schleicher, A., Speckmann, E. ‐., & Zilles, K. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.068 · Cited by 82
Anxiety at the Frontier of Molecular Medicine
Weinberger, D. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441612 · Cited by 82
GABAA receptor subtype selectivity underlying selective anxiolytic effect of baicalin
Wang, F., Xu, Z., Ren, L., Tsang, S. Y., & Xue, H. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.040 · Cited by 81
Hines, R. M., Maric, H. M., Hines, D. J., Modgil, A., Panzanelli, P., Nakamura, Y., Nathanson, A. J., Cross, A., Deeb, T., Brandon, N. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05481-1 · Cited by 72
Self-citationGABAA receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone
Ren, L., Wang, F., Xu, Z., Chan, W. M., Zhao, C., & Xue, H. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.024 · Cited by 80
Role of GABAA receptors in cognition
Möhler, H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371328 · Cited by 79
Self-citationStreet, L. J., Sternfeld, F., Jelley, R. A., Reeve, A. J., Carling, R. W., Moore, K. W., McKernan, R. M., Sohal, B., Cook, S. M., Pike, A. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0407613 · Cited by 79
Mani, V., Ramasamy, K., Ahmad, A., Parle, M., Shah, S. A. A., & Majeed, A. B. A. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.11.037 · Cited by 78
Chandra, D., Korpi, E. R., Miralles, C. P., De Blas, A. L., & Homanics, G. E. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-30 · Cited by 69
Lieberman, J. A. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0105 · Cited by 77
Atack, J. R., Maubach, K. A., Wafford, K. A., O'Connor, D. V., Rodrigues, A. D., Evans, D. C., Tattersall, F. D., Chambers, M. S., MacLeod, A. M., Eng, W., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157636 · Cited by 77
Beleboni, R. O., Carolino, R. O. G., Pizzo, A. B., Castellan-Baldan, L., Coutinho‐Netto, J., dos Santos, W. F., & Coimbra, N. C. (2004) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-6913-z · Cited by 77
Juvenile stress-induced alteration of maturation of the GABAA receptor α subunit in the rat
Jacobson-Pick, S., Elkobi, A., Vander, S., Rosenblum, K., & Richter-Levin, G. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008559 · Cited by 68
Savić, M. M., Huang, S., Furtmüller, R., Clayton, T., Huck, S., Obradovic, D. I., Ugrešić, N. D., Sieghart, W., Bokonjić, D. R., & Cook, J. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301403 · Cited by 77
Toriizuka, K., Kamiki, H., Ohmura, N., Fujii, M., Hori, Y., Fukumura, M., Hirai, Y., Isoda, S., Nemoto, Y., & Ida, Y. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.12.054 · Cited by 77
Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor γ2 subunit
Cope, D. W., Wulff, P., Oberto, A., Aller, M. I., Capogna, M., Ferraguti, F., Halbsguth, C., Hoeger, H., Jolin, H. E., Jones, A., et al. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.03.007 · Cited by 71
Genetic Epidemiology of Alcohol-Induced Blackouts
Nelson, E. C., Heath, A. C., Bucholz, K. K., Madden, P. A. F., Fu, Q. J., Knopik, V. S., Lynskey, M. T., Whitfield, J. B., Statham, D. J., & Martin, N. G. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.257 · Cited by 76
Lotus Leaf Alkaloid Extract Displays Sedative–Hypnotic and Anxiolytic Effects through GABAA Receptor
Yan, M., Chang, Q., Zhong, Y., Xiao, B., Feng, L., Cao, F., Pan, R.-L., Zhang, Z., Liao, Y., & Liu, X. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b04141 · Cited by 75
The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models
Belzung, C. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00005 · Cited by 75
Pinna, G., & Rasmusson, A. M. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02234.x · Cited by 74
Girish, C., Raj, V., Arya, J., & Sadasivam, B. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.003 · Cited by 74
A half century of γ-aminobutyric acid
Smart, T. G., & Stephenson, F. A. (2019) · Brain and Neuroscience Advances · doi:10.1177/2398212819858249 · Cited by 74
Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite
Carlson, J. N., Haskew-Layton, R. E., Wacker, J. L., Maisonneuve, I. M., Glick, S. D., & Jerussi, T. P. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00851-2 · Cited by 74
Kopp, C., Rudolph, U., Keist, R., & Tobler, I. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02651.x · Cited by 73
Self-citationRole of GABRA2 in Moderating Subjective Responses to Alcohol
Roh, S., Matsushita, S., Hara, S., Maesato, H., Matsui, T., Suzuki, G., Miyakawa, T., Ramchandani, V. A., Li, T., & Higuchi, S. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01357.x · Cited by 73
Crestani, F., Assandri, R., Täuber, M., Martin, J. R., & Rudolph, U. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00159-4 · Cited by 73
Self-citation
Metadata
- Authors
- Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H.
- Affiliations
- University of Zurich (CH)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Rudolph, Uwe
- Venue
- Nature
- Published
- 1999-10
- Volume
- 401
- Issue
- 6755
- Pages
- 796-800
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083623577
- Cited by
- 1,172
- References
- 18
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 20 · 2023: 15 · 2022: 26 · 2021: 20 · 2020: 21 · 2019: 27 · 2018: 46 · 2017: 38 · 2016: 33 · 2015: 25 · 2014: 50 · 2013: 47 · 2012: 54
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, benzodiazepine binding site, allosteric modulation, diazepam, anxiolytic effects, sedation, amnesia, anticonvulsant activity, ethanol potentiation, myorelaxation, receptor subtypes, limbic system, motor neurons, monoaminergic neurons, drug design
- MeSH terms
- Animals, Anticonvulsants, Arginine, Benzodiazepines, Diazepam, Histidine, Hypnotics and Sedatives, Memory, Mice, Inbred C57BL, Muscle Relaxants, Central, Receptors, GABA-A, Anti-Anxiety Agents, Drug Design, Point Mutation, GABA Modulators, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.